Bear Sterns Health Innoventures
Executive Summary
Former Roche and BASF/Knoll execs are founding partners in Bears Sterns venture capital fund Health Innoventures. Former Roche research execs Jurgen Drews, Fritz Buhler and Stefan Ryser and former Knoll VP-Business Development Elizabeth Czerepak are partners in the fund, which will invest in early- to mid-stage biotech and information technology companies. The fund has $212 mil. in committed capital